BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 8385158)

  • 1. Expression of c-myc and bcl-2 oncogene products in Reed-Sternberg cells independent of presence of Epstein-Barr virus.
    Jiwa NM; Kanavaros P; van der Valk P; Walboomers JM; Horstman A; Vos W; Mullink H; Meijer CJ
    J Clin Pathol; 1993 Mar; 46(3):211-7. PubMed ID: 8385158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of bcl-2 protein and transcription of the Epstein-Barr virus bcl-2 homologue BHRF-1 in Hodgkin's disease: implications for different pathogenic mechanisms.
    Jiwa NM; Oudejans JJ; Bai MC; Van den Brule AJ; Horstman A; Vos W; Van der Valk P; Kluin PM; Walboomers JM; Meijer CJ
    Histopathology; 1995 Jun; 26(6):547-53. PubMed ID: 7665145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of Epstein-Barr virus harbouring small and intermediate-sized cells in Hodgkin's disease. Is there a relationship with Reed-Sternberg cells?
    Jiwa NM; Kanavaros P; De Bruin PC; van der Valk P; Horstman A; Vos W; Mullink H; Walboomers JM; Meijer CJ
    J Pathol; 1993 Jun; 170(2):129-36. PubMed ID: 8393921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. bcl-2 expression in Hodgkin's disease. Correlation with the t(14;18) translocation and Epstein-Barr virus.
    Bhagat SK; Medeiros LJ; Weiss LM; Wang J; Raffeld M; Stetler-Stevenson M
    Am J Clin Pathol; 1993 May; 99(5):604-8. PubMed ID: 8388163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Epstein-Barr virus latent gene products and related cellular activation and adhesion molecules in Hodgkin's disease and non-Hodgkin's lymphomas arising in patients without overt pre-existing immunodeficiency.
    Kanavaros P; Jiwa M; van der Valk P; Walboomers J; Horstman A; Meijer CJ
    Hum Pathol; 1993 Jul; 24(7):725-9. PubMed ID: 8100553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Encoded latent membrane protein 1 of Epstein-Barr virus on follicular dendritic cells in residual germinal centres in Hodgkin's disease.
    van Gorp J; Jacobse KC; Broekhuizen R; Alers J; van den Tweel JG; de Weger RA
    J Clin Pathol; 1994 Jan; 47(1):29-32. PubMed ID: 8132805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of bcl-2 protein and Epstein-Barr virus latent membrane protein in Hodgkin's disease.
    Kordek R; Biernat W; Kupnicka D; Woźniak L
    Pol J Pathol; 1994; 45(4):279-81. PubMed ID: 7697330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus infection and bcl-2 proto-oncogene expression. Separate events in the pathogenesis of Hodgkin's disease?
    Khan G; Gupta RK; Coates PJ; Slavin G
    Am J Pathol; 1993 Nov; 143(5):1270-4. PubMed ID: 8238244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical detection of Epstein-Barr virus-encoded latent membrane protein in Reed-Sternberg cells and variants of Hodgkin's disease.
    Pinkus GS; Lones M; Shintaku IP; Said JW
    Mod Pathol; 1994 May; 7(4):454-61. PubMed ID: 7520586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression of the EBV latent membrane protein (LMP-1) is independent of CD23 and bcl-2 in Reed-Sternberg cells in Hodgkin's disease.
    Armstrong AA; Gallagher A; Krajewski AS; Jones DB; Wilkins BS; Onions DE; Jarrett RF
    Histopathology; 1992 Jul; 21(1):72-3. PubMed ID: 1321789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of Epstein-Barr virus in the Reed-Sternberg cells of Hodgkin's disease occurring in Peru.
    Chang KL; Albújar PF; Chen YY; Johnson RM; Weiss LM
    Blood; 1993 Jan; 81(2):496-501. PubMed ID: 8380728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus DNA in Reed-Sternberg cells of Hodgkin's disease is frequently associated with CR2 (EBV receptor) expression.
    Jiwa NM; Van der Valk P; Mullink H; Vos W; Horstman A; Maurice MM; Olde-Weghuis DE; Walboomers JM; Meijer CJ
    Histopathology; 1992 Jul; 21(1):51-7. PubMed ID: 1321787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the methods for the detection of Epstein-Barr virus nucleic acids and related gene products in Hodgkin's disease.
    Brousset P; Meggetto F; Chittal S; Bibeau F; Arnaud J; Rubin B; Delsol G
    Lab Invest; 1993 Oct; 69(4):483-90. PubMed ID: 8231115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus and Hodgkin's disease: a comparative immunological, in situ hybridization, and polymerase chain reaction study.
    Lauritzen AF; Hørding U; Nielsen HW
    APMIS; 1994 Jul; 102(7):495-500. PubMed ID: 7917218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of EBV, proliferation rate, and Bcl-2 expression in Hodgkin's disease in childhood.
    Claviez A; Tiemann M; Peters J; Kreipe H; Schneppenheim R; Parwaresch R
    Ann Hematol; 1994 Feb; 68(2):61-6. PubMed ID: 8148417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of the expression of Epstein-Barr virus latent membrane protein and in situ hybridization with biotinylated BamHI-W probes in Hodgkin's disease.
    Delsol G; Brousset P; Chittal S; Rigal-Huguet F
    Am J Pathol; 1992 Feb; 140(2):247-53. PubMed ID: 1310829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of a 30-base pair deletion in the Epstein-Barr virus (EBV) latent membrane protein 1 gene and of strain type B EBV in Mexican classical Hodgkin's disease and reactive lymphoid tissue.
    Dirnhofer S; Angeles-Angeles A; Ortiz-Hidalgo C; Reyes E; Gredler E; Krugmann J; Fend F; Quintanilla-Martinez L
    Hum Pathol; 1999 Jul; 30(7):781-7. PubMed ID: 10414496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of the detection of Epstein-Barr virus DNA in lymph nodes in patients with Hodgkin's disease.
    Knecht H; Joske DJ; Bachmann E; Sahli R; Odermatt BF
    Leuk Lymphoma; 1992 Nov; 8(4-5):319-25. PubMed ID: 1337849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of Epstein-Barr virus in Hodgkin-Reed-Sternberg cells : no evidence for the persistence of integrated viral fragments inLatent membrane protein-1 (LMP-1)-negative classical Hodgkin's disease.
    Staratschek-Jox A; Kotkowski S; Belge G; Rüdiger T; Bullerdiek J; Diehl V; Wolf J
    Am J Pathol; 2000 Jan; 156(1):209-16. PubMed ID: 10623669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of EBV encoded latent membrane protein 1 (LMP-1) and bcl-2 protein in childhood and adult Hodgkin's disease: application of microwave irradiation for antigen retrieval.
    Kaczorowski S; Kaczorowska M; Christensson B
    Leuk Lymphoma; 1994 Apr; 13(3-4):273-83. PubMed ID: 7914127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.